Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Quinolinyl and benzothiazolyl modulators

Quinolinyl and benzothiazolyl modulators

US Patent 6583157 · Granted Jun 24, 2003

Estimated economic value: $3,590,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Heterocyclic compounds as triggering receptor expressed on myeloid cells 2 agoni2025
Heterocyclic compounds as triggering receptor expressed on myeloid cells 2 agoni2025
Heterocyclic compounds as triggering receptor expressed on myeloid cells 2 agoni2025
Heterocyclic compounds as triggering receptor expressed on myeloid cells 2 agoni2024
Heterocyclic compounds as triggering receptor expressed on myeloid cells 2 agoni2024
Heterocyclic compounds as triggering receptor expressed on myeloid cells2 agonis2023
Heterocyclic compounds as triggering receptor expressed on myeloid cells 2 agoni2023
Opioid receptor modulators and products and methods related thereto2022
Compounds that inhibit MCL-1 protein2022
Inhibitors of glucocorticoid receptor2021
Alkyl substituted triazole compounds as agonists of the APJ Receptor2021
Inhibitors of glucocorticoid receptor2021